The German Cancer Research Center is the largest cancer research institute in Europe and a member of the Helmholtz Association of National Research Centers. In over 90 divisions and research groups, more than 3,000 employees, of which more than 1,200 are scientists, are investigating the mechanisms of cancer, identifying cancer risk factors and are trying to find strategies to prevent people from getting cancer. They are developing novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful.
TRON – Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz GmbH is a biopharmaceutical research organization that pursues new diagnostics and drugs for the treatment of cancer. A focus of TRON is the development of novel platforms for individualized therapies and biomarkers, translating basic research into drug applications. TRON partners with academic institutions, biotech companies and the pharmaceutical industry, executing research with leading-edge technologies and supporting the development of innovative drugs to promote human health.
The University Medical Center Mainz stands for a close integration of top-level medicine, research and teaching. As the only University Medical Center in Rhineland-Palatinate, the University Medical Center in Mainz is already making tomorrow's medicine today - because it ensures that the latest findings of medical research reach the patient quickly.
With around 31,000 students from over 120 nations, Johannes Gutenberg University Mainz is one of the largest and most diverse universities in Germany. JGU unites almost all academic disciplines, including the Mainz University Medical Center, the Mainz Academy of Fine Arts, the Mainz School of Music, and the Faculty of Translation Studies, Linguistics, and Cultural Studies in Germersheim.